Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Praxis Precision Medicines

Tracked across 3 events · 20 articles · First seen Apr 02, 2026 · Last active Jul 02, 2026

Sentiment
28
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 75
Business
Impact: Praxis Precision Medicines announced that the United States — Food and Drug Administration accepted its New Drug Application for ulixacaltamide HCl, moving the company closer to commercial launch of a new therapy for essential tremor.
Apr 14, 2026 · 6 articles
1 10
Business
Impact: Praxis Precision Medicines, Inc. granted restricted stock unit awards to new non-executive employees under its 2024 Inducement Plan, which is a positive for the company's ability to attract and retain talent.
Apr 02, 2026 · 8 articles
2 0
Business
Impact: Dr. Daniel Baker provided critical guidance during the merger of Praxis Precision Medicines and Argus retinal prosthesis, which led to the formation of Vivani Medical.
Jun 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Praxis Precision Medicines live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.